Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraperitoneal (IP) Cisplatin Combined With Intravenous Gemcitabine + Nab-paclitaxel in Patients With Pancreatic Cancer With Peritoneal Metastasis

NCT05222204 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT05222204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05222204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraperitoneal (IP) Cisplatin Combined With Intravenous Gemcitabine + Nab-paclitaxel in Patients With Pancreatic Cancer With Peritoneal Metastasis
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Completed
Start date
May 15, 2022
Completion date
December 12, 2024
Enrollment
91 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic neoplasm